CAPITALSTARS PRESENT NIFTY FUTURES TIPS OUTLOOK UPDATE : 08 SEP 2020

 Capital Stars Financial Research Private Limited 

Nifty Outlook 

08TH SEP 2020 

NIFTY FUTURES DAILY TECHNICAL OUTLOOK

TECHNICAL CHART:

DAILY PIVOTS LEVELS:

TECHNICAL VIEW:

Closing bell: Sensex today ended at 38,417, up 60 points, or 0.16 per cent, with Hindustan Unilever (HUL) being the top gainer and Mahindra & Mahindra (M&M), down over 3 per cent, the biggest loser. 

The Nifty50 index, meanwhile, ended at 11,355, up 21 points, or 0.19 per cent. India VIX declined nearly 2.5 per cent to 21.6 levels.

Nifty futures have resistance 11450 after crossing this level it can reach up to the level 11600. In the downside nifty futures has support near 11300 after breaking this support it can slip till level of 11100.

BANK NIFTY CHART:

DAILY PIVOTS LEVELS:

TECHNICAL VIEW:

In next trading session bank nifty futures have resistance 23300 after crossing this level it can reach up to the level of 24000.In the downside bank nifty futures has support near 22500 after breaking this support it can slip till level of 21800.

Global Indices: 

US STOCKS - U.S. Futures NASDAQ 100 are down 1.27 % while Dow futures up 0.59 % and S&P 500 Futures down 0.81 %. 

European stock markets trading in a positive zone with DAX up 1.91 % and FTSE up 2.36 % respectively and all the major bourses in the region trading in positive territory.

Disclaimer

The information and views in this report & all the service we provide are believed to be reliable, but we do not accept any responsibility for errors of fact or opinion. Investors have the right to choose the product/s that suits them the most. Sincere efforts have been made to present the right investment perspective. The information contained herein is based on analysis and up on sources that we consider reliable. This material is for personal information and based upon it & takes no responsibility. The information given herein should be treated as only factor, while making investment decision. The report does not provide individually tailor-made investment advice. My research recommends that investors independently evaluate particular investments and strategies, and encourages investors to seek the advice of a financial adviser. Capitalstars shall not be responsible for any transaction conducted based on the information given in this report, which is in violation of rules and regulations of regulators. The price projections shown are not necessarily indicative of future price performance. The information herein, together with all estimates and forecasts, can change without notice. It is understood that anyone who is browsing through the site has done so at his free will and does not read any views expressed as a recommendation for which either the site or its owners or anyone can be held responsible for. Investment & Trading in Securities Markets are always subjected to market risk. 

Capitalstars Financial Research Private Ltd., Reserves all Rights.

INVESTMENT AND TRADING IN SECURITIES MARKET IS ALWAYS SUBJECTED TO MARKET RISK.

CAPITALSTARS STOCK MARKET UPDATE : 21 AUGUST 2019

CAPITALSTARS  INVESTMENT  ADVISER

Hindalco Industries Ltd Falls 2.51%, S&P BSE Metal index Drops 1.46%

Hindalco Industries Ltd has lost 13.68% over last one month compared to 17.34% fall in S&P BSE Metal index and 2.01% drop in the SENSEX

Hindalco Industries Ltd lost 2.51% today to trade at Rs 174.8. The S&P BSE Metal index is down 1.46% to quote at 8624.13. The index is down 17.34 % over last one month. Among the other constituents of the index, Vedanta Ltd decreased 2.11% and National Aluminium Company Ltd lost 1.48% on the day. The S&P BSE Metal index went down 34.45 % over last one year compared to the 2.66% fall in benchmark SENSEX.

Hindalco Industries Ltd has lost 13.68% over last one month compared to 17.34% fall in S&P BSE Metal index and 2.01% drop in the SENSEX. On the BSE, 45169 shares were traded in the counter so far compared with average daily volumes of 4.34 lakh shares in the past one month. The stock hit a record high of Rs 259.7 on 04 Oct 2018. The stock hit a 52-week low of Rs 171.7 on 05 Aug 2019.

CLICK HERE FOR GET DETAILS & JOIN OUR BEST ADVISORY  -

Visit our Link : https://bit.ly/2u2GUhK

Visit My Website : https://bit.ly/1h8KZUM

CAPITALSTARS CALL US : 9977499927

Equity Tips , Intraday Stock Tips , FreeTrading Tips  , Sebi Registered advisory 

CAPITALSTARS STOCK MARKET UPDATE : 21 AUGUST 2019

USFDA observations take toll on Dr Reddy's Lab

Dr.Reddy's Laboratories announced that the audit of its formulations manufacturing plant at Duvvada, Visakhapatnam by the US FDA, has been completed, and a Form 483 with 8 observations has been issued.

Shares of the pharma major were down by 2.03% to Rs 2,503. On the BSE, 7572 shares were traded in the counter. The scrip has outperformed the market in past one year, up 7.34% as against Sensex's 2.48% rise. 

The drug maker after market hours yesterday, 20 August 2019 said that it will address this comprehensively within the stipulated timeline.

The S&P BSE Sensex was down 23.92 points or 0.06% to 37,304.09. 

Dr. Reddy's Laboratories is an integrated pharmaceutical company. Through its three businesses - pharmaceutical services & active ingredients, global generics and proprietary products - Dr. Reddy's offers a portfolio of products and services including APIs, custom pharmaceutical services, generics,biosimilars and differentiated formulations. 

CLICK HERE FOR GET DETAILS & JOIN OUR BEST ADVISORY  -

Visit our Link : https://bit.ly/2u2GUhK

Visit My Website : https://bit.ly/1h8KZUM

CAPITALSTARS CALL US : 9977499927

Equity Tips , Intraday Stock Tips , FreeTrading Tips  , Sebi Registered advisory 

CAPITALSTARS STOCK MARKET UPDATE : TATA CHEMICALS JUMPS AFTER Q1 : 09 AUGUST 2019

CAPITALSTARS  INVESTMENT  ADVISER

Tata Chemicals jumps after decent Q1 results.

Tata Chemicals gained 5.39% to Rs 595.45 at 9:38 IST on the BSE after consolidated net profit rose 19% to Rs 245.18 crore on 5.6% rise in net sales to Rs 2896.94 crore in Q1 June 2019 over Q1 June 2018.

The S&P BSE Sensex was up by 176.71 points or 0.47% at 37,504.07. 

On the BSE, 52000 shares were traded in the counter so far compared with average daily volumes of 25000 shares in the past two weeks.The stock had hit an intraday high of Rs 600.95 and an intraday low of Rs 578.05 so far during the day.The stock hit a 52-week high of Rs 781.55 on 3 September 2018 and a 52-week low of Rs 548 on 5 August 2019. 

Earnings before interest tax depreciation and amortization (EBITDA) grew 20.57% to Rs 592 crore in Q1 June 2019 as compared to Rs 491 crore in Q1 June 2018.

The company's net debt dropped 4.49% to Rs 1871 crore in Q1 June 2019 as compared to Rs 1959 crore in Q4 March 2018. 

Commenting on company's Q1 performance, R. Mukundan, managing director, Tata Chemicals said, "The Company has posted a healthy growth on a consolidated basis across all business segments.In basic chemistry products business, we will continue to be most cost-efficient soda ash, bicarbonate and salt business.Company's investment in a Bicarbonate unit in the United Kingdom using innovative carbon capture process and Mithapur plant expansion will provide significant thrust to growth.We are also happy to have received the environment clearance for the expansion at Mithapur plant. The company will continue to focus on nutritional science and material sciences business towards scale by strengthening the innovative funnel to ensure aggressive growth in the Specialty Products Business.” 

Tata Chemicals is a global company with interests in businesses that focus on basic chemistry products, consumer and specialty products.The company is also a pioneer and market leader in India's branded Iodised salt segment. The company is currently is the world's third largest producer of soda ash with manufacturing facilities in Asia, Europe, Africa and North America. 

CLICK HERE FOR GET DETAILS & JOIN OUR BEST ADVISORY  -

Visit our Link : https://bit.ly/2u2GUhK

Visit My Website : https://bit.ly/1h8KZUM

CAPITALSTARS CALL US : 9977499927

Equity Tips , Intraday Stock Tips , FreeTrading Tips  , Sebi Registered advisory 

CAPITALSTARS STOCK MARKET UPDATE : AUROBINDO PHARMA STRONG Q1 : 08 AUGUST 2019

CAPITALSTARS  INVESTMENT  ADVISER

Aurobindo Pharma spurts after strong Q1 earnings.

Aurobindo Pharma gained 4.78% to Rs 581.55 at 10:13 IST on the BSE after consolidated net profit jumped 41.6% to Rs 645.18 crore on 28.1% increase in net sales to Rs 5356.84 crore in Q1 June 2019 over Q1 June 2018.

The S&P BSE Sensex was up by 101.3 points or 0.28% at 36,791.8. 

On the BSE, 1.23 lakh shares were traded in the counter so far compared with average daily volumes of 80000 shares in the past two weeks.The stock had hit an intraday high of Rs 585.25 and an intraday low of Rs 571.9 so far during the day. The stock hit a 52-week high of Rs 838 on 30 April 2019 and a 52-week low of Rs 537 on 5 August 2019. 

The company's earnings before interest tax depreciation and amortization (EBITDA) increased 47.1% to Rs 1146.4 crore in Q1 June 2019 compared with Rs 779.2 crore in Q1 June 2018.The EBITDA margin was at 21.1% in Q1 June 2019 as compared to 18.3% in Q1 June 2018. 

The spending on research & development (R&D) was at Rs 243 crore (4.5% of revenue) in Q1 June 2019. 

The consolidated finance cost increased 68.9% to Rs 49.9 crore in Q1 June 2019 as compared to Rs 29.5 crore in Q1 June 2018. 

Revenue from US formulations registered a robust growth in Q1 June 2019. The revenue surged 42.3% to Rs 2688.4 crore in Q1 June 2019 from Rs 1889.6 crore in Q1 June 2018. 

Commenting on the company's performance, N. Govindarajan, managing director of the company said, “We have started the year with a healthy performance.Enhancing our quality management practices and adhering to the regulatory requirements continues to be our highest priority.During the quarter, we have commissioned Eugia's manufacturing facility and launched 5 Oncology & Hormonal products in the US market.” 

Aurobindo Pharma manufactures generic pharmaceuticals and active pharmaceutical ingredients. The company's manufacturing facilities are approved by several leading regulatory agencies like US FDA, UK MHRA, EU, Japan PMDA, WHO, Health Canada, South Africa MCC, Brazil ANVISA. 

CLICK HERE FOR GET DETAILS & JOIN OUR BEST ADVISORY  -

Visit our Link : https://bit.ly/2u2GUhK

Visit My Website : https://bit.ly/1h8KZUM

CAPITALSTARS CALL US : 9977499927

Equity Tips , Intraday Stock Tips , FreeTrading Tips  , Sebi Registered advisory 

CAPITALSTARS STOCK MARKET UPDATE : TATA STEEL LTD FALLS 3.28% : 07 AUGUST 2019

CAPITALSTARS  INVESTMENT  ADVISER

Tata Steel Ltd Falls 3.28%, S&P BSE Metal index Drops 1.79%.

Tata Steel Ltd has lost 17.16% over last one month compared to 13.81% fall in S&P BSE Metal index and 4.52% drop in the SENSEX.

Tata Steel Ltd lost 3.28% today to trade at Rs 387.7. The S&P BSE Metal index is down 1.79% to quote at 8952.72. The index is down 13.81 % over last one month.Among the other constituents of the index, Jindal Steel & Power Ltd decreased 3.23% and NMDC Ltd lost 3.06% on the day.The S&P BSE Metal index went down 31.48 % over last one year compared to the 1.84% fall in benchmark SENSEX. 

Tata Steel Ltd has lost 17.16% over last one month compared to 13.81% fall in S&P BSE Metal index and 4.52% drop in the SENSEX.On the BSE, 1.52 lakh shares were traded in the counter so far compared with average daily volumes of 5.6 lakh shares in the past one month.The stock hit a record high of Rs 646.7 on 21 Sep 2018. The stock hit a 52-week low of Rs 387 on 07 Aug 2019.

CLICK HERE FOR GET DETAILS & JOIN OUR BEST ADVISORY  -

Visit our Link : https://bit.ly/2u2GUhK

Visit My Website : https://bit.ly/1h8KZUM

CAPITALSTARS CALL US : 9977499927

Equity Tips , Intraday Stock Tips , FreeTrading Tips  , Sebi Registered advisory 

CAPITALSTARS STOCK MARKET UPDATE : DILIP BUILDCON SLIPS Q1 : 06 AUGUST 2019

CAPITALSTARS  INVESTMENT  ADVISER

Dilip Buildcon slips after weak Q1 figures.

Dilip Buildcon dropped 1.93% to Rs 382.7 at 10:39 IST on the BSE after consolidated net profit fell 54.9% to Rs 100.42 crore on 3.4% fall in net sales to Rs 2436.44 crore in Q1 June 2019 over Q1 June 2018.

The S&P BSE Sensex was up by 133.45 points or 0.36% at 36,833.75. 

On the BSE, 14000 shares were traded in the counter so far compared with average daily volumes of 15000 shares in the past two weeks. The stock had hit an intraday high of Rs 393 and an intraday low of Rs 367.65 so far during the day.The stock hit a 52-week high of Rs 915.75 on 6 August 2018 and a 52-week low of Rs 311.55 on 5 February 2019. 

On standalone basis, the company's net profit fell 50.9% to Rs 125.24 crore on 6.1% fall in net sales to Rs 2287.97 crore in Q1 June 2019 over Q1 June 2018. 

Standalone earnings before interest tax depreciation and amortization (EBITDA) fell 3.99% to Rs 424.2 crore in Q1 June 2019 from Rs 441.8 crore in Q1 June 2018.The standalone EBITDA margin rose to 18.44% in Q1 June 2019 from 18.07% in Q1 June 2018. 

The company's net order book as on 30 June 2019 stood at Rs 19,029 crore. 74.35% of the order book is constituted by roads and highways project, special bridge projects contribute 3.81%,mining contributes 14.37%, irrigation projects contribute 2.82%, metro projects contribute 2.22%, tunnel projects contribute 2.26% and urban development projects contribute 0.17%. 

Dilip Buildcon (DBL) is one of the leading full-service infrastructure companies with construction capabilities in roads & bridges, mining, water sanitation, sewage, dams, irrigation, industrial, commercial and residential buildings with a presence in over 17 states .

CLICK HERE FOR GET DETAILS & JOIN OUR BEST ADVISORY  -

Visit our Link : https://bit.ly/2u2GUhK

Visit My Website : https://bit.ly/1h8KZUM

CAPITALSTARS CALL US : 9977499927

Equity Tips , Intraday Stock Tips , FreeTrading Tips  , Sebi Registered advisory